Alerts will be sent to your verified email
Verify Email
SANJIVIN
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sanjivani Paranteral Ltd is an international pharmaceutical company offering a diverse range of high-quality and affordable products such as oral solids, small volume parenterals, and sterile powder formulations.
Sanjivani Paranteral major competitors are BDH Inds, iStreet Network, Nectar Lifesciences, Bafna Pharma, Lyka Labs, Syschem (India), Quest Laboratories.
Market Cap of Sanjivani Paranteral is ₹237 Crs.
While the median market cap of its peers are ₹236 Crs.
Sanjivani Paranteral seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Feb | May Aug Nov | Mar Jun Sep Dec | Dec | |||||||||||||||
| Investor Presentation | Feb | May Aug Nov | Feb Mar Jun Sep Dec | Feb Mar May Sep Oct Nov Dec | Dec | ||||||||||||||
| Conference Call | Feb | Mar Jun Nov | Mar Jun Sep Dec | Sep Dec | |||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
